Dyne Therapeutics Cash Flow Statement (2019-2026) | DYN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-29.95M	-42.58M	-51.78M	-35.55M	-52.31M	-41.38M	-38.80M	-43.97M	-64.53M	-60.08M	-65.94M	-66.16M	-64.91M	-96.29M	-89.52M	-115.27M	-109.26M	-108.32M	-108.47M	-116.52M
Share-based Compensation (Quarter)	0.40M	3.64M	6.01M	4.49M	3.03M	3.83M	3.83M	4.62M	4.75M	4.88M	5.73M	19.91M	6.74M	0.50M	10.48M	13.02M	0.10M	11.08M	11.23M	13.08M
Gains from Sales and Divestitures (Quarter)	0.13M	0.20M	0.25M	0.02M	0.09M	0.24M	0.29M	0.10M	0.20M	0.39M	0.49M	0.24M	0.63M	0.87M	1.07M	0.57M	0.78M	1.03M	1.27M	0.16M
Gains from Investment Securities (Quarter)	0.01M	1.16M	0.30M	0.17M	0.11M	0.40M	-0.37M	9.28M	9.16M	0.27M	-8.00M	0.30M	1.22M	0.49M	-0.01M	8.83M	1.48M	3.15M	2.30M	-0.03M
Non-cash Items (Quarter)	94.78M	60.68M	36.95M	2.30M	2.82M	42.54M	34.88M	4.37M	4.59M	4.99M	38.73M	4.16M	178.02M	3.52M	61.02M	3.87M	3.91M	14.50M	52.78M	49.38M
Cash from Operations (Quarter)	-46.15M	-26.95M	-28.07M	-50.74M	-30.91M	-42.80M	-29.19M	-46.91M	-55.64M	-50.60M	-35.01M	-78.54M	-54.87M	-74.63M	-84.33M	-105.89M	-94.70M	-90.78M	-111.83M	-144.92M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Amortization of Deferred Charges (Quarter)	0.65M	0.70M	0.74M	0.60M	0.41M	0.24M	0.03M	-0.18M	-0.36M	-0.36M	-0.19M	-0.52M	-1.27M	-0.98M	-0.84M	-0.62M	-0.46M	-0.37M	-0.39M	-0.27M
Depreciation & Amortization (CF) (Quarter)	0.20M	0.30M	0.39M	0.42M	0.50M	0.40M	0.38M	0.40M	0.40M	0.40M	0.40M	0.40M	0.40M	0.40M	0.45M	0.50M	0.50M	0.50M	0.47M	0.60M
Change in Working Capital
Change in Accured Expenses (Quarter)	0.97M	4.83M	6.03M	-6.27M	1.54M	-1.16M	4.65M	-6.53M	-1.37M	9.46M	21.41M	-28.76M	7.38M	13.41M	-0.99M	-8.60M	7.84M	18.47M	-9.46M	-4.80M
Investing Activities
Capital Expenditures (Quarter)	0.69M	-0.59M	0.04M	0.17M	1.50M	-1.66M	0.09M	0.23M	-0.22M	0.02M	0.70M	0.19M	-0.19M	0.05M	2.33M	0.03M	0.34M	18.43M		0.08M
Change in Acquisitions & Divestments (Quarter)			4.44M	2.52M	0.24M		0.40M	1.83M						1.75M	8.81M	2.97M	5.50M	0.00M	9.38M	28.65M
Cash from Investing Activities (Quarter)	-6.43M	-2.85M	-0.23M	-2.14M	18.44M	51.66M	19.24M	27.06M	17.23M	12.82M	26.20M	-179.84M	11.17M	-19.40M	-16.01M	1.46M	6.77M	-37.97M	0.98M	-2.39M
Financing Activities
Other financing activities (Quarter)																			0.06M	0.03M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)																			49.45M
Change in Capital Stock
Shares Issued (Quarter)	0.03M	0.46M	0.09M	0.02M	0.10M	0.07M	36.67M	0.59M	51.78M		-50.42M	10.92M	86.95M	-64.66M	64.66M	140.65M	-138.09M	138.09M	377.70M	1.31M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)	0.03M	0.46M	0.09M	0.02M	0.10M	0.07M	37.20M	28.82M	24.91M	0.45M	0.15M	408.39M	379.86M	18.01M	3.64M	141.24M	100.77M	217.33M	430.96M	7.06M
Change in Cash (Quarter)	-52.56M	-29.34M	-28.21M	-52.86M	-12.37M	8.92M	27.25M	8.97M	-13.50M	-37.33M	-8.66M	150.01M	336.17M	-76.02M	-96.71M	36.81M	12.85M	88.58M	320.12M	-140.25M
Free Cash Flow (Quarter)	-46.84M	-26.37M	-28.11M	-50.91M	-32.40M	-41.14M	-29.28M	-47.14M	-55.42M	-50.62M	-35.71M	-78.73M	-54.68M	-74.68M	-86.66M	-105.92M	-95.04M	-109.20M	-111.83M	-145.00M
Net Cash Flow (Quarter)	-52.56M	-29.34M	-28.21M	-52.86M	-12.37M	8.92M	27.25M	8.97M	-13.50M	-37.33M	-8.66M	150.01M	336.17M	-76.02M	-96.71M	36.81M	12.85M	88.58M	320.12M	-140.25M

Research Tools

Dyne Therapeutics Cash Flow Statement (2019-2026) | DYN

Create an account

Sign In

Reset Password